Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Liabilities (2016 - 2026)

Skinvisible's Total Liabilities history spans 16 years, with the latest figure at $10.4 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 10.75% to $10.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.4 million, a 10.75% increase, with the full-year FY2025 number at $10.4 million, up 10.75% from a year prior.
  • Total Liabilities hit $10.4 million in Q4 2025 for Skinvisible, up from $10.1 million in the prior quarter.
  • Over the last five years, Total Liabilities for SKVI hit a ceiling of $10.4 million in Q4 2025 and a floor of $5.1 million in Q1 2021.
  • Historically, Total Liabilities has averaged $8.0 million across 5 years, with a median of $8.8 million in 2023.
  • Biggest five-year swings in Total Liabilities: skyrocketed 43.82% in 2023 and later increased 1.22% in 2025.
  • Tracing SKVI's Total Liabilities over 5 years: stood at $5.6 million in 2021, then increased by 22.05% to $6.9 million in 2022, then soared by 33.37% to $9.2 million in 2023, then increased by 2.13% to $9.4 million in 2024, then grew by 10.75% to $10.4 million in 2025.
  • Business Quant data shows Total Liabilities for SKVI at $10.4 million in Q4 2025, $10.1 million in Q3 2025, and $9.9 million in Q2 2025.